비교리스트

 카트 문의
시장보고서
상품코드
1421669

암 생검 시장, 점유율, 규모, 동향, 산업 분석 보고서 : 제품 유형별, 용도별, 지역별, 부문별 예측(2024-2032년)

Cancer Biopsy Market Share, Size, Trends, Industry Analysis Report, By Type (Liquid, Biopsy, Tissue Biopsy, and Others); By Product Type; By Application; By Region; Segment Forecast, 2024- 2032
발행일: | 리서치사: Polaris Market Research | 페이지 정보: 영문 117 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

Polaris Market Research의 최신 조사에 따르면, 세계 암 생검 시장 규모는 2032년까지 920억 9,000만 달러에 달할 것으로 예상됩니다. 이 조사 보고서는 현재 시장 역학에 대한 자세한 통찰력과 미래 시장 성장에 대한 분석을 제공합니다.

생검은 질병을 발견하기 위해 신체의 모든 부위에서 조직을 채취하는 의료 시술입니다. 바늘로 채취하거나 수술로 채취하는 등 다양한 방법이 사용되며, MRI 및 CT 스캔과 같은 영상 검사는 이상을 식별 할 수 있지만 암세포와 비 암세포를 구별할 수는 없습니다. 따라서 생검은 악성 종양의 진단을 확정하는 데 필수적이며 상세한 세포 분석을 수반합니다.

체액 생검의 발전은 암 생검 시장의 성장에 큰 영향을 미치고 있습니다. 이 혁신적인 기술은 혈류 내 유전 물질을 분석하여 비침습적 접근 방식으로 특정 암종을 탐지하고 모니터링할 수 있게 해줍니다.

생검은 다양한 암종의 생물학적 특성에 대한 중요한 통찰력을 제공합니다. 이 정보는 잠재적인 신약 개발 표적을 식별하고 새로운 치료법을 평가하기 위한 임상시험을 계획하는 데 유용합니다. 생검은 또한 치료 반응을 모니터링하고 내성 메커니즘을 파악하여 보다 효과적인 약물 및 병용요법 개발에 기여하고 있습니다.

암 생검 시장은 많은 문제에 직면해 있습니다. 자원이 부족한 지역에서는 고급 생검 기술과 분자 프로파일링 기술을 쉽게 이용할 수 없습니다. 또한, 복잡한 게놈 데이터를 해석하기 위해서는 전문적인 지식이 필요하며, 종양학 분야의 지속적인 교육과 훈련의 필요성이 강조되고 있습니다. 침습적인 생검 절차는 환자에게 불편함을 유발하여 환자가 생검을 기피하는 결과를 초래합니다. 또한, 생검 절차 및 관련 기술의 비용은 개인과 의료 시스템에 따라서는 너무 비쌀 수 있습니다. 양질의 생검 서비스에 대한 동등한 접근성을 보장하고 암 진단 및 치료에 최대한의 효과를 내기 위해서는 이러한 문제를 극복하는 것이 필수적입니다.

암 생검 시장 보고서 하이라이트

  • 액체 생검 분야는 광범위한 사용으로 인해 예측 기간 동안 가장 높은 CAGR로 성장할 것으로 예상됩니다.
  • 키트 및 소모품 부문은 2022년 가장 큰 시장 점유율을 차지했는데, 이는 주로 비용 효율성과 높은 성능에 기인합니다.
  • 유방암 분야는 2022년 큰 시장 수익 점유율을 차지했는데, 이는 주로 높은 유병률에 기인합니다.
  • 북미가 2022년 시장의 대부분을 차지할 것으로 예상됩니다.

목차

제1장 서론

제2장 주요 요약

제3장 조사 방법

제4장 세계의 암 생검 시장별 통찰

  • 암 생검 시장 - 용도 현황
  • 암 생검 시장 역학
    • 성장 촉진요인과 기회
    • 성장 억제요인과 과제
  • PESTEL 분석
  • 암 생검 시장 용도 동향
  • 밸류체인 분석
  • COVID-19의 영향 분석

제5장 세계의 암 생검 시장, 유형별

  • 주요 조사 결과
  • 서론
  • 체액 생검
  • 조직 생검
  • 기타

제6장 세계의 암 생검 시장, 제품 유형별

  • 주요 조사 결과
  • 서론
  • 키트 및 소모품
  • 장비
  • 서비스

제7장 세계의 암 생검 시장, 용도별

  • 주요 조사 결과
  • 서론
  • 유방암
  • 자궁경부암
  • 폐암
  • 결장직장암
  • 기타

제8장 세계의 암 생검 시장, 지역별

  • 주요 조사 결과
  • 서론
    • 암 생검 시장 평가, 지역별, 2019-2032년
  • 암 생검 시장 - 북미
    • 북미 : 암 생검 시장, 유형별, 2019-2032년
    • 북미 : 암 생검 시장, 용도별, 2019-2032년
    • 북미 : 암 생검 시장, 제품 유형별, 2019-2032년
    • 암 생검 시장 - 미국
    • 암 생검 시장 - 캐나다
  • 암 생검 시장 - 유럽
    • 유럽 : 암 생검 시장, 유형별, 2019-2032년
    • 유럽 : 암 생검 시장, 용도별, 2019-2032년
    • 유럽 : 암 생검 시장, 제품 유형별, 2019-2032년
    • 암 생검 시장 - 영국
    • 암 생검 시장 - 프랑스
    • 암 생검 시장 - 독일
    • 암 생검 시장 - 이탈리아
    • 암 생검 시장 - 스페인
    • 암 생검 시장 - 네덜란드
    • 암 생검 시장 - 러시아
  • 암 생검 시장 - 아시아태평양
    • 아시아태평양 : 암 생검 시장, 유형별, 2019-2032년
    • 아시아태평양 : 암 생검 시장, 용도별, 2019-2032년
    • 아시아태평양 : 암 생검 시장, 제품 유형별, 2019-2032년
    • 암 생검 시장 - 중국
    • 암 생검 시장 - 인도
    • 암 생검 시장 - 말레이시아
    • 암 생검 시장 - 일본
    • 암 생검 시장 - 인도네시아
    • 암 생검 시장 - 한국
  • 암 생검 시장 - 중동 및 아프리카
    • 중동 및 아프리카 : 암 생검 시장, 유형별, 2019-2032년
    • 중동 및 아프리카 : 암 생검 시장, 용도별, 2019-2032년
    • 중동 및 아프리카 : 암 생검 시장, 제품 유형별, 2019-2032년
    • 암 생검 시장 - 사우디아라비아
    • 암 생검 시장 - 아랍에미리트(UAE)
    • 암 생검 시장 - 이스라엘
    • 암 생검 시장 - 남아프리카
  • 암 생검 시장 - 라틴아메리카
    • 라틴아메리카 : 암 생검 시장, 유형별, 2019-2032년
    • 라틴아메리카 : 암 생검 시장, 용도별, 2019-2032년
    • 라틴아메리카 : 암 생검 시장, 제품 유형별, 2019-2032년
    • 암 생검 시장 - 멕시코
    • 암 생검 시장 - 브라질
    • 암 생검 시장 - 아르헨티나

제9장 경쟁 구도

  • 확대와 인수 분석
    • 확대
    • 인수
  • 제휴/협업/합의/공개

제10장 기업 개요

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • Hologic, Inc.
  • Illumina, Inc.
  • Koninklijke Philips N.V.
  • Myriad Genetics, Inc.
  • NeoGenomics, Inc.
  • QIAGEN N.V.
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • Veracyte, Inc.
LSH 24.02.21

The global cancer biopsy market size is expected to reach USD 92.09 billion by 2032, according to a new study by Polaris Market Research. The report "Cancer Biopsy Market Share, Size, Trends, Industry Analysis Report, By Type (Liquid, Biopsy, Tissue Biopsy, and Others); By Product Type; By Application; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

A biopsy is a medical procedure that involves extracting tissue from any part of the body to detect diseases. Different methods, including needle-based or surgical extraction, are used. Imaging tests such as MRIs and CT scans can identify abnormalities, but they cannot differentiate between cancerous and non-cancerous cells. Therefore, biopsies are essential to confirm malignancy diagnoses and involve detailed cellular analysis.

Advancements in liquid biopsies have significantly influenced the growth of the cancer biopsy market. This innovative technique analyzes genetic material in the bloodstream, making it possible to detect and monitor specific cancer types in a non-invasive approach.

Biopsies offer crucial insights into the biology of different cancer types. This information is instrumental in identifying potential drug targets and designing clinical trials to evaluate new therapies. Biopsies are also used to monitor treatment response and identify mechanisms of resistance, contributing to the development of more effective drugs and combination therapies.

The cancer biopsy market is facing numerous challenges. Advanced biopsy techniques and molecular profiling technologies are not readily available in areas with limited resources. Additionally, interpreting complex genomic data requires specialized expertise, which highlights the need for ongoing education and training in oncology. Invasive biopsy procedures can cause discomfort to patients, leading to reluctance to undergo the process. Moreover, the cost of biopsy procedures and related technologies can be too high for some individuals and healthcare systems. It is vital to overcome these challenges to ensure equal access to high-quality biopsy services and to maximize their impact on cancer diagnosis and treatment.

Cancer Biopsy Market Report Highlights

  • The liquid biopsy segment is expected to grow at the highest CAGR during the projected period on account of wide usage
  • The kits and consumables segment accounted for the largest market share in 2022, which is mainly driven by cost-effectiveness and higher performance.
  • The breast cancer segment held a significant market revenue share in 2022, mainly due to its high prevalence rate
  • North America region dominated the market with a majority share in 2022, owing to exponential growth in the technology and advanced healthcare system
  • The global key market players include: Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Hologic, Inc

Polaris Market Research has segmented the cancer biopsy market report based on type, product type, application, and region:

Cancer Biopsy, Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Liquid, Biopsy
  • Tissue Biopsy
  • Others

Cancer Biopsy, Product Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Kits and Consumables
  • Instruments
  • Services

Cancer Biopsy, Application Outlook (Revenue - USD Billion, 2019 - 2032)

  • Breast Cancer
  • Cervical Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Others

Cancer Biopsy, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Cancer Biopsy Market Insights

  • 4.1. Cancer Biopsy Market - Application Snapshot
  • 4.2. Cancer Biopsy Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increase in cancer cases is projected to spur the product demand
      • 4.2.1.2. Advancements in molecular diagnostics
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High costs associated with cancer biopsy tests
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Cancer Biopsy Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Cancer Biopsy Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • 5.3. Liquid, Biopsy
    • 5.3.1. Global Cancer Biopsy Market, by Liquid, Biopsy, by Region, 2019-2032 (USD Billion)
  • 5.4. Tissue Biopsy
    • 5.4.1. Global Cancer Biopsy Market, by Tissue Biopsy, by Region, 2019-2032 (USD Billion)
  • 5.5. Others
    • 5.5.1. Global Cancer Biopsy Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Cancer Biopsy Market, by Product Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • 6.3. Kits and Consumables
    • 6.3.1. Global Cancer Biopsy Market, by Kits and Consumables, by Region, 2019-2032 (USD Billion)
  • 6.4. Instruments
    • 6.4.1. Global Cancer Biopsy Market, by Instruments, by Region, 2019-2032 (USD Billion)
  • 6.5. Services
    • 6.5.1. Global Cancer Biopsy Market, by Services, by Region, 2019-2032 (USD Billion)

7. Global Cancer Biopsy Market, by Application

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • 7.3. Breast Cancer
    • 7.3.1. Global Cancer Biopsy Market, by Breast Cancer, By Region, 2019-2032 (USD Billion)
  • 7.4. Cervical Cancer
    • 7.4.1. Global Cancer Biopsy Market, by Cervical Cancer, By Region, 2019-2032 (USD Billion)
  • 7.5. Lung Cancer
    • 7.5.1. Global Cancer Biopsy Market, by Lung Cancer, By Region, 2019-2032 (USD Billion)
  • 7.6. Colorectal Cancer
    • 7.6.1. Global Cancer Biopsy Market, by Colorectal Cancer, By Region, 2019-2032 (USD Billion)
  • 7.7. Others
    • 7.7.1. Global Cancer Biopsy Market, by Others, By Region, 2019-2032 (USD Billion)

8. Global Cancer Biopsy Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Cancer Biopsy Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Cancer Biopsy Market - North America
    • 8.3.1. North America: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
    • 8.3.2. North America: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
    • 8.3.3. North America: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.3.4. Cancer Biopsy Market - U.S.
      • 8.3.4.1. U.S.: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.3.5. Cancer Biopsy Market - Canada
      • 8.3.5.1. Canada: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • 8.4. Cancer Biopsy Market - Europe
    • 8.4.1. Europe: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.4.4. Cancer Biopsy Market - UK
      • 8.4.4.1. UK: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.4.5. Cancer Biopsy Market - France
      • 8.4.5.1. France: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.4.6. Cancer Biopsy Market - Germany
      • 8.4.6.1. Germany: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.4.7. Cancer Biopsy Market - Italy
      • 8.4.7.1. Italy: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.4.8. Cancer Biopsy Market - Spain
      • 8.4.8.1. Spain: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.4.9. Cancer Biopsy Market - Netherlands
      • 8.4.9.1. Netherlands: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.4.10. Cancer Biopsy Market - Russia
      • 8.4.10.1. Russia: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • 8.5. Cancer Biopsy Market - Asia Pacific
    • 8.5.1. Asia Pacific: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.5.4. Cancer Biopsy Market - China
      • 8.5.4.1. China: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.5.5. Cancer Biopsy Market - India
      • 8.5.5.1. India: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.5.6. Cancer Biopsy Market - Malaysia
      • 8.5.6.1. Malaysia: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.5.7. Cancer Biopsy Market - Japan
      • 8.5.7.1. Japan: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.5.8. Cancer Biopsy Market - Indonesia
      • 8.5.8.1. Indonesia: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.5.9. Cancer Biopsy Market - South Korea
      • 8.5.9.1. South Korea: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • 8.6. Cancer Biopsy Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.6.4. Cancer Biopsy Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.6.5. Cancer Biopsy Market - UAE
      • 8.6.5.1. UAE: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.6.6. Cancer Biopsy Market - Israel
      • 8.6.6.1. Israel: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.6.7. Cancer Biopsy Market - South Africa
      • 8.6.7.1. South Africa: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • 8.7. Cancer Biopsy Market - Latin America
    • 8.7.1. Latin America: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.7.4. Cancer Biopsy Market - Mexico
      • 8.7.4.1. Mexico: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.7.5. Cancer Biopsy Market - Brazil
      • 8.7.5.1. Brazil: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.7.6. Cancer Biopsy Market - Argentina
      • 8.7.6.1. Argentina: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Abbott Laboratories
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Becton, Dickinson and Company
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Bio-Rad Laboratories, Inc.
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Danaher Corporation
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. F. Hoffmann-La Roche Ltd.
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Hologic, Inc.
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Illumina, Inc.
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Koninklijke Philips N.V.
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Myriad Genetics, Inc.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. NeoGenomics, Inc.
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. QIAGEN N.V.
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Siemens Healthineers AG
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Sysmex Corporation
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Thermo Fisher Scientific Inc.
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. Veracyte, Inc.
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제